C WorldWide Group’s Edwards Lifesciences EW Stock Holding History

C WorldWide Group’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$41.7M	Sell	460,657 -510	-0.1%	-$42.7K	1%	18
2026 Q1	$36.9M	Sell	461,167 -186	-0%	-$15.3K	0.79%	19
2025 Q4	$39.3M	Buy	461,353 +64,835	+16%	+$5.32M	0.69%	23
2025 Q3	$30.8M	Sell	396,518 -260	-0.1%	-$20.3K	0.48%	24
2025 Q2	$31M	Sell	396,778 -1,540	-0.4%	-$115K	0.42%	28
2025 Q1	$28.9M	Sell	398,318 -60,235	-13%	-$4.31M	0.36%	28
2024 Q4	$33.9M	Sell	458,553 -450,681	-50%	-$31.5M	0.41%	24
2024 Q3	$60M	Sell	909,234 -2,131	-0.2%	-$155K	0.62%	26
2024 Q2	$84.2M	Hold	911,365	–	–	0.91%	19
2024 Q1	$87.1M	Buy	911,365 +405,800	+80%	+$34.1M	0.99%	17
2023 Q4	$38.5M	Buy	505,565 +26,169	+5%	+$1.82M	0.52%	22
2023 Q3	$33.2M	Hold	479,396	–	–	0.45%	24
2023 Q2	$45.2M	Sell	479,396 -12,736	-3%	-$1.11M	0.58%	21
2023 Q1	$40.7M	Buy	492,132 +115,129	+31%	+$9.05M	0.56%	21
2022 Q4	$28.1M	Buy	377,003 +39,902	+12%	+$3.08M	0.37%	24
2022 Q3	$27.9M	Hold	337,101	–	–	0.38%	21
2022 Q2	$32.1M	Buy	337,101 +6,685	+2%	+$692K	0.4%	21
2022 Q1	$38.9M	Sell	330,416 -4,313	-1%	-$484K	0.42%	20
2021 Q4	$43.4M	Sell	334,729 -15,000	-4%	-$1.75M	0.41%	20
2021 Q3	$39.6M	Buy	349,729 +1,165	+0.3%	+$133K	0.41%	20
2021 Q2	$36.1M	Buy	348,564 +7,253	+2%	+$684K	0.37%	22
2021 Q1	$28.5M	Hold	341,311	–	–	0.28%	30
2020 Q4	$31.1M	Hold	341,311	–	–	0.31%	31
2020 Q3	$27.2M	Buy	341,311 +54,070	+19%	+$4.22M	0.31%	29
2020 Q2	$19.9M	Hold	287,241	–	–	0.23%	38
2020 Q1	$18.1M	Hold	287,241	–	–	0.25%	31
2019 Q4	$22.3M	Hold	287,241	–	–	0.27%	28
2019 Q3	$21.1M	Sell	287,241 -75,588	-21%	-$5.31M	0.27%	26
2019 Q2	$22.3M	Buy	362,829 +225,000	+163%	+$13.6M	0.28%	25
2019 Q1	$8.79M	Hold	137,829	–	–	0.11%	42
2018 Q4	$7.04M	Sell	137,829 -139,350	-50%	-$7.05M	0.1%	46
2018 Q3	$16.1M	Hold	277,179	–	–	0.21%	30
2018 Q2	$13.4M	Hold	277,179	–	–	0.19%	31
2018 Q1	$12.9M	Hold	277,179	–	–	0.2%	32
2017 Q4	$10.4M	Hold	277,179	–	–	0.15%	46
2017 Q3	$10.1M	Sell	277,179 -11,607	-4%	-$443K	0.14%	46
2017 Q2	$11.4M	Sell	288,786 -28,398	-9%	-$1.04M	0.17%	44
2017 Q1	$9.95M	Hold	317,184	–	–	0.17%	46
2016 Q4	$9.91M	Buy	+317,184	New	+$10.3M	0.19%	42

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

C WorldWide Group's EW Position: Q2 2026 in Review

C WorldWide Group reduced its Edwards Lifesciences (EW) stake by 0.11% in Q2 2026, selling an estimated $42.7K and leaving 460,657 shares worth $41.7M. The position accounts for 1% of the portfolio, ranked #18.

C WorldWide Group first reported a position in EW in Q4 2016 and has held it in 39 quarters since. The position peaked at $87.1M in Q1 2024. 1,184 funds tracked by Wall St. Rank hold EW as of Q2 2026.

C WorldWide Group held 460,657 shares of Edwards Lifesciences worth $41.7M as of Q2 2026.
C WorldWide Group sold 510 Edwards Lifesciences shares in Q2 2026, an estimated $42.7K.
Edwards Lifesciences made up 1% of C WorldWide Group's portfolio in Q2 2026, its #18 holding.
C WorldWide Group first reported a position in Edwards Lifesciences in Q4 2016 and has held it in 39 quarters since.
C WorldWide Group's Edwards Lifesciences position peaked at $87.1M in Q1 2024.
1,184 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on C WorldWide Group's 13F filing for Q2 2026, filed 4 Aug 2026.